Unicycive Therapeutics (UNCY) Other Non Operating Income (2021 - 2024)

Unicycive Therapeutics (UNCY) has 3 years of Other Non Operating Income data on file, last reported at -$11.8 million in Q1 2024.

• Quarterly Other Non Operating Income fell 13.36% year-over-year to -$11.8 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was -$22.1 million (down 113.36% YoY) and the FY2023 annual result came in at -$9.8 million, down 162733.33% from the prior year.
• Other Non Operating Income retreated to -$11.8 million in Q1 2024, from -$10.4 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $19000.0 in Q1 2021 to a low of -$11.8 million in Q1 2024.
• A 3-year average of -$7.4 million and a median of -$10.4 million in 2023 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 13.36% in 2024, down 13.36% in 2024.
• Tracing UNCY's Other Non Operating Income over 3 years: stood at $19000.0 in 2021, then plunged by 54694.74% to -$10.4 million in 2023, then slipped by 13.36% to -$11.8 million in 2024.
• The last three Other Non Operating Income figures came in at -$11.8 million (Q1 2024), -$10.4 million (Q1 2023), and $19000.0 (Q1 2021), per Business Quant data.